- Current status
- AHSCT is a standard of care of RRMS
- Wykłady na kursie specjalizacyjnym – transplantologia
- AHSCT is better choice than DMDs in MS as a treatment of cases progressing after first line treatment – multicenter randomised trial.
- CPX-351 (Vyxeos) – new drug that improves treatment in older patients with secondary AML
Monthly Archives: January 2017
I wrote this post over a year ago but forgot to post it. Interesting study. There is an interesting publication in BMJ on cancer screening. Although the cancer screening dose reduce the mortality from the specific cancer it does … Continue reading
Nice story of first bone marrow transplants: http://www.signalsblog.ca/the-story-of-the-first-bone-marrow-transplant/